Johnson & Johnson reports $100 million in quarterly sales from Covid vaccine

J&J's financial results come as the company's Covid-19 vaccine has been put on pause in the United States.

from Health and Science https://ift.tt/3dvNjdc
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH